LobbyingHansa Biopharma lobbying by quarter
Hansa Biopharma's latest lobbying report covers Q2 2026, at $60K. The four quarters Q4 2025–Q3 2026 total $180K. Its first report covers Q3 2024; the issues it reports most are Health Issues and Budget/Appropriations.
Hansa Biopharma
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $180K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2024
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2024 | $60K | 1 |
| Q4 2024 | $60K | 1 |
| Q1 2025 | $60K | 1 |
| Q2 2025 | $60K | 1 |
| Q3 2025 | $60K | 1 |
| Q4 2025 | $60K | 1 |
| Q1 2026 | $60K | 1 |
| Q2 2026 | $60K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$300K · 8 reports
- Budget and appropriations$180K · 6 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)8 reports
- HOUSE OF REPRESENTATIVES6 reports
- SENATE6 reports
- Veterans Affairs, Dept of (VA)4 reports
Firms it paid
| Firm | ||
|---|---|---|
| Tarplin, Downs & Young | $480K | 8 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CHARLOTTE SPEARS IVANCIC | Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner | Q2 2026 |
| JEFF RECZEK | Dir. CDC Washington, Professional Staff Sen. Appropriations Cmte, Program Examiner OMB, Program Analyst Dept. of Transportation | Q2 2026 |
| JENNIFER B YOUNG | Asst. Sec. for Leg.- HHS; Dep. Asst. Sec for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff. Sen. Cmte. on Finance | Q2 2026 |
| PAMELA SMITH | Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Sen. HELP Cmte.; Staff Dir., Sen. HELP Cmte.; Counsel to Asst. AG, Civil Div., Dept. of Justice; Spec. Counsel, Ofc of Leg. Affairs, Dept. of Justice; Counsel and LA, Sen. Carol Moseley-Braun | Q2 2026 |
| PARICK BRAERTON CARROLL | Leg Asst. Rep. Ray LaHood, Leg Dir. Rep. Kevin Yoder, PSM Senate Appropriations Cmte. | Q2 2026 |
| ELIZABETH T MURRAY | Senior Policy Advisor, Democratic Whip Steny Hoyer; Leg. Asst., Rep. Mike Thompson, Rep. Bob Matsui, and Sen. Bob Graham | Q3 2025 |
| EMILY H MURRY | Staff Dir., Sub. Cmte. on Helath, Ways and Means Cmte; Sr. Policy Adivsor, Maj. Leader McCarthy; Policy Advisor, Maj. Whip McCarthy; Prof. Staff, Republicans Study Cmte.; Leg. Aide, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price | Q3 2025 |
| LAURA FRIEDEL | Leg. Asst., Sen. Zell Miller, Leg. Dir., Sen. Richard Shelby, Clerk, Staff Dir., Sen. Appropriations Committee | Q3 2025 |
| MARGARET JOSEPH | CoS for Sen. Kyrsten Sinema, CoS for Rep. Kyrsten Sinema, CoS for Rep. Bobby Bright, CoS for Rep. Jim Matheson, Clerk for House Rules Cmte. | Q3 2025 |
| PETER FISE | Health Counsel for Sen. Cmte on Finance, Health Counsel for Sen. Jeanne Shaheen, Staff Assistant for House Cmte on Oversight & Government Reform | Q3 2025 |
| RAISSA H DOWNS | Prin. Dep. Asst. Sec for Leg.-HHS; Dep. Asst. Sec. for Leg.-HSS; Staff Dir., Sub Cmte. on Employment, Sen. HELP Cmte. | Q3 2025 |
| KIMBERLY LYNN BRANDT | Sr. Counsel and Dir. External Affairs - HHS OIG; Prin. Dep. Administrator for Policy and Operations, and Dir. of Medicare Program Integrity - CMS; Chief Oversight and General Counsel, Sen. Cmte. on Finance | Q4 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Tarplin, Downs & Young | $60K |
| 04/20for Q1 | Tarplin, Downs & Young | $60K |
| 01/20for Q4 2025 | Tarplin, Downs & Young | $60K |
| 25/10/15for Q3 2025 | Tarplin, Downs & Young | $60K |
| 25/07/21for Q2 2025 | Tarplin, Downs & Young | $60K |
| 25/04/16for Q1 2025 | Tarplin, Downs & Young | $60K |
| 25/01/16for Q4 2024 | Tarplin, Downs & Young | $60K |
| 24/10/21for Q3 2024 | Tarplin, Downs & Young | $60K |
| 24/10/21for Q3 2024 | Tarplin, Downs & Young | Under $5,000 |